Aptose Biosciences announced it regained compliance with Nasdaq’s minimum bid price requirement, as its shares maintained a closing bid price of $1.00 or grea ...

Aptose Biosciences Inc. ("Aptose” or the "Company”) (NASDAQ: APTO, TSX: APS), a clinical-stage precision oncology company ...

The worst result, after buying shares in a company (assuming no leverage), would be if you lose all the money you ...

Market makers ensure the efficiency and liquidity of the marketplace and the spread between bid and ask prices is their compensation. Bids can be made live, online, through brokers, or through a ...

In January 2025, the Securities and Exchange Commission (the Commission) approved amendments to the minimum bid price ...

Primega Group Holdings Limited (Nasdaq: PGHL) (the 'Company”) announced that, on March 12, 2025, the Company received a letter from the Listing Qualifications staff of The Nasdaq Stock Market ('Nasdaq ...

The press release indicates that the company had previously been non-compliant with Nasdaq's minimum bid price rule, which raises concerns about its financial stability. The mention of potential ...

(the “Company”) received a letter from the Listing Qualifications staff of The Nasdaq Stock Market (“Nasdaq”) notifying the Company that based on the closing bid price of the Company for ...

This press release includes "forward-looking statements" within the meaning of the "safe harbor" provisions of the United States Private Securities Litigation Reform Act of 1995. Forward-looking ...